Global Clinical Trials Software Market Size is valued at USD 0.9 Billion in 2024 and is predicted to reach USD 3.8 Billion by the year 2034 at a 15.8% CAGR during the forecast period for 2025-2034.
Recently pharmaceutical companies started using clinical trial management services to improve the accuracy and efficiency of clinical trials. A clinical trial is a procedure that studies new treatments and drugs to check their effects on human health.
The rising use of clinical trial management services, fast adoption of cloud-based solutions, increased healthcare expenditure, high prevalence of chronic & infectious diseases, growing government investments for clinical trial services and research are projected to augument the market growth over the forecast period. Furthermore, rising innovations of clinical trials software drive the market growth. For instance, in April 2021, Bioclinica (US) introduced the new source document management solution that combines advanced software with redaction and translation services to offer support to global research sites and trial management teams.
However, the expensive clinical trials software and limited knowledge on advanced technologies among healthcare professionals may restrict the market growth during the estimated timeframe.
The clinical trials software market is segmented into the type of deployment, type of delivery, type of end-user, features of software, trial design, type of technology and region. The type of deployment segment comprises on-cloud and on-premises. The on-cloud segment is projected to dominate the market during the forecast period due to the surging use of cloud-based software for clinical trials. The market is classified into web-based and remote monitoring based on the type of delivery. The web-based delivery type is expected to be the fastest-growing segment of this market. It reduces R&D costs and offers cost-effective, easy accessibility to web-based clinical trial solutions.
Type of End-User, the market segmented into pharmaceuticals, biotechnology, CROs. features of software, the market segmented into EDC, eCOA/ePRO, eConsent, Trial Design the market segmented into decentralized, site-based, hybrid, randomized, case control, cohort, Type of Technology the market segmented into IVRS, and IWRS.
The pharmaceutical category will lead this market in the coming years due to the high demand for automated clinical trial management services. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
North America dominated the clinical trials software market in 2020 and will continue its trend over the forecast period. Additionally, the Asia-Pacific market is likely to witness rapid growth in the next few years due to the growing pharmaceutical companies, increasing clinical trial studies, and high demand for web-based and cloud-based solutions for clinical trial processes.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 0.9 Billion |
|
Revenue Forecast In 2034 |
USD 3.8 Billion |
|
Growth Rate CAGR |
CAGR of 15.8% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Type of Deployment, Type of Delivery, Type of End-User, Features of Software, Trial Design, Type of Technology |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Advarra, Antidote Technologies, Inc., ArisGlobal , AssistRx, athenahealth, Inc., Axiom Real-Time Metrics, BioClinica Inc. , BSI Business Systems Integration AG, Calyx , Castor EDC, Chronicles, Clario, Clarivate, ClinCapture, Clincase, Clinical Research, CLIRINX, Cloudbyz, Dacima Software Inc., Datatrak Int. , Florence HC , IBM , Instem , IQVIA , MasterControl Inc., Medidata Solutions Inc, MedNet Solutions Inc., Novatek International, Octalsoft , Openclinica, Oracle Corporation, Parexel International Corp., RealTime Software Solutions LLC, Reify Health, Inc., Signant Health, Statsols, TrialKit , Veeva Systems Inc., WIRB-Copernicus Group, and Other prominent players. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Clinical Trials Software Market Snapshot
Chapter 4. Global Clinical Trials Software Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: Type of Deployment Estimates & Trend Analysis
5.1. Type of Deployment & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Deployment:
5.2.1. On-Cloud
5.2.2. On-Premises
Chapter 6. Market Segmentation 2: Type of Delivery Estimates & Trend Analysis
6.1. Type of Delivery & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Delivery:
6.2.1. Web-Based
6.2.2. Remote Monitoring
Chapter 7. Market Segmentation 3: Type of End-User Estimates & Trend Analysis
7.1. Type of End-User & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of End-User:
7.2.1. Pharmaceuticals
7.2.2. Biotechnology
7.2.3. Cros
Chapter 8. Market Segmentation 4: Features of Software Estimates & Trend Analysis
8.1. Features of Software & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following Features of Software:
8.2.1. EDC
8.2.2. eCOA/ePRO
8.2.3. eConsent
Chapter 9. Market Segmentation 5: Trial Design Estimates & Trend Analysis
9.1. Trial Design & Market Share, 2024 & 2034
9.1.1. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following Trial Design:
9.1.2. Decentralized
9.1.3. Site-Based
9.1.4. Hybrid
9.1.5. Randomized
9.1.6. Case Control
9.1.7. Cohort
Chapter 10. Market Segmentation 6: Type of Technology Estimates & Trend Analysis
10.1. Type of Technology & Market Share, 2024 & 2034
10.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following Type of Technology:
10.2.1. Pulmonary
10.2.2. Vascular
10.2.3. Cardiology Surgery
10.2.4. Neurology
10.2.5. Radiology
Chapter 11. Clinical Trials Software Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Deployment, 2021-2034
11.1.2. North America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Delivery, 2021-2034
11.1.3. North America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of End-User, 2021-2034
11.1.4. North America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Features of Software, 2021-2034
11.1.5. North America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Trial Design, 2021-2034
11.1.6. North America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Technology, 2021-2034
11.1.7. North America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.2. Europe
11.2.1. Europe Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Deployment, 2021-2034
11.2.2. Europe Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Delivery, 2021-2034
11.2.3. Europe Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of End-User, 2021-2034
11.2.4. Europe Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Features of Software, 2021-2034
11.2.5. Europe Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Trial Design, 2021-2034
11.2.6. Europe Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Technology, 2021-2034
11.2.7. Europe Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.3. Asia Pacific
11.3.1. Asia Pacific Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Deployment, 2021-2034
11.3.2. Asia Pacific Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Delivery, 2021-2034
11.3.3. Asia-Pacific Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of End-User, 2021-2034
11.3.4. Asia-Pacific Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Features of Software, 2021-2034
11.3.5. Asia-Pacific Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Trial Design, 2021-2034
11.3.6. Asia-Pacific Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Technology, 2021-2034
11.3.7. Asia Pacific Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.4. Latin America
11.4.1. Latin America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Deployment, 2021-2034
11.4.2. Latin America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Delivery, 2021-2034
11.4.3. Latin America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of End-User, 2021-2034
11.4.4. Latin America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Features of Software, 2021-2034
11.4.5. Latin America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Trial Design, 2021-2034
11.4.6. Latin America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Technology, 2021-2034
11.4.7. Latin America Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.5. Middle East & Africa
11.5.1. Middle East & Africa Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Deployment, 2021-2034
11.5.2. Middle East & Africa Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Delivery, 2021-2034
11.5.3. Middle East & Africa Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of End-User, 2021-2034
11.5.4. Middle East & Africa Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Features of Software, 2021-2034
11.5.5. Middle East & Africa Clinical Trials Software Market Revenue (US$ Million) Estimates and Trial Design, 2021-2034
11.5.6. Middle East & Africa Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts Type of Technology, 2021-2034
11.5.7. Middle East & Africa Clinical Trials Software Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Advarra,
12.2.2. Antidote Technologies, Inc.,
12.2.3. ArisGlobal ,
12.2.4. AssistRx,
12.2.5. athenahealth, Inc.,
12.2.6. Axiom Real-Time Metrics,
12.2.7. BioClinica Inc.
12.2.8. BSI Business Systems Integration AG
12.2.9. Calyx
12.2.10. Castor EDC,
12.2.11. Chronicles,
12.2.12. Clario,
12.2.13. Clarivate,
12.2.14. ClinCapture,
12.2.15. Clincase,
12.2.16. Clinical Research,
12.2.17. CLIRINX,
12.2.18. Cloudbyz,
12.2.19. Dacima Software Inc.,
12.2.20. Datatrak Int.
12.2.21. Florence HC
12.2.22. IBM
12.2.23. Instem
12.2.24. IQVIA
12.2.25. MasterControl Inc.,
12.2.26. Medidata Solutions Inc,
12.2.27. MedNet Solutions Inc.,
12.2.28. Novatek International,
12.2.29. Octalsoft ,
12.2.30. Openclinica,
12.2.31. Oracle Corporation,
12.2.32. Parexel International Corp.,
12.2.33. RealTime Software Solutions LLC,
12.2.34. Reify Health, Inc.,
12.2.35. Signant Health,
12.2.36. Statsols,
12.2.37. TrialKit ,
12.2.38. Veeva Systems Inc.,
12.2.39. WIRB-Copernicus Group,
12.2.40. Other prominent players.
Global Clinical Trials Software Market, by Type of Deployment,
Global Clinical Trials Software Market, by Type of Delivery,
Clinical Trials Software Market- Type of End-User
Clinical Trials Software Market- Features of Software
Clinical Trials Software Market- Trial Design
Clinical Trials Software Market Type of Technology
Global Clinical Trials Software Market, by Region,
North America Clinical Trials Software Market, by Country,
Europe Clinical Trials Software Market, by Country,
Asia Pacific Clinical Trials Software Market, by Country,
Latin America Clinical Trials Software Market, by Country,
Middle East & Africa Clinical Trials Software Market, by Country,
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
